The invention herein relates to a pharmaceutical composition containing loratadine and derivatives thereof which is suitable for use in soft capsule dosage forms. The compounds are polymethine compounds of the general formula A detailed description of general formula may be found in the specification. The 1st to Nth image members have 1st to Nth surfaces respectively.